BCM
HELP

Boxer Capital Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Boxer Capital Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
790,000
+150,000
+23% +$750K 0.39% 40
2026
Q1 		$3.07M Sell
640,000
-75,000
-10% -$485K 0.4% 39
2025
Q4 		$5.85M Buy
+715,000
New +$4.6M 1.28% 22

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Boxer Capital Management's HELP Position: Q2 2026 in Review

Boxer Capital Management increased its Helus Pharma Inc. Common Stock (HELP) stake by 23% in Q2 2026, buying an estimated $750K and bringing the position to 790,000 shares worth $5.22M. The position accounts for 0.39% of the portfolio, ranked #40.

Boxer Capital Management first reported a position in HELP in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.85M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Boxer Capital Management held 790,000 shares of Helus Pharma Inc. Common Stock worth $5.22M as of Q2 2026.
  • Boxer Capital Management bought 150,000 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $750K.
  • Helus Pharma Inc. Common Stock made up 0.39% of Boxer Capital Management's portfolio in Q2 2026, its #40 holding.
  • Boxer Capital Management first reported a position in Helus Pharma Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
  • Boxer Capital Management's Helus Pharma Inc. Common Stock position peaked at $5.85M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.